α-Galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice

Molecular Medicine

Volumn 16, Issue 5-6, 2010, Pages 216-221

  Higuchi, Koji ^a,b   Yoshimitsu, Makoto ^a,b   Fan, Xin ^a   Guo, Xiaoxin ^a   Rasaiah, Vanessa I ^a   Yen, Jennifer ^a   Tei, Chuwa ^b   Takenaka, Toshihiro ^b   Medin, Jeffrey A ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE TRANSACTIVATOR FUSION PROTEIN; GLOBOTRIAOSYLCERAMIDE; HYBRID PROTEIN; LENTIVIRUS VECTOR; MANNOSE 6 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; FABRY DISEASE; GENE EXPRESSION; HEART; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE THERAPY;

ALPHA-GALACTOSIDASE; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; GENE THERAPY; GENES, TAT; HELA CELLS; HIV; HUMANS; KIDNEY; LENTIVIRUS; MICE; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TRIHEXOSYLCERAMIDES;

EID: 77951963462     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00163     Document Type: Article

References (17)

1. Brady RO, et al. (1967) Enzymatic defect in Fabry's disease. Ceramidetrihexosidase defi-ciency. N. Engl. J. Med. 276:1163-7
2. Nakao S, et al. (1995) An atypical variant of Fabry's disease in men with left ventricular hy-pertrophy. N. Engl. J. Med. 333:288-93
3. Sachdev B, et al. (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 105:1407-11
4. Banikazemi M, et al. (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146:77-86
5. Weidemann F, et al. (2009) Long-term effects of enzyme replacement therapy on Fabry cardiomy-opathy: evidence for a better outcome with early treatment. Circulation. 119:524-9
6. West M, et al. (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. J. Am. Soc. Nephrol. 20:1132-9
7. Medin JA, et al. (1996) Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vec- tor. Proc. Natl. Acad. Sci. U. S. A. 93:7917-22
8. Takenaka T, et al. (2000) Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc. Natl. Acad. Sci. U. S. A. 97:7515-20
9. Qin G, et al. (2001) Preselective gene therapy for Fabry disease. Proc. Natl. Acad. Sci. U. S. A. 98:3428-33
10. Yoshimitsu M, et al. (2004) Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc. Natl. Acad. Sci. U. S. A. 101:16909-14
11. Yoshimitsu M, et al. (2007) Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/ progenitor cells. Gene Ther. 14:256-65
12. Xia H, Mao Q, Davidson BL. (2001) The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19:640-4
13. Orii KO, et al. (2005) Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol. Ther. 12:345-52
14. Lee KO, et al. (2005) Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain. Biochem. Bio-phys. Res. Commun. 337:701-7
15. Derossi D, et al. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:18188-93
16. Vives E, Brodin P, Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translo- cates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:16010-7
17. King JE, Eugenin EA, Buckner CM, Berman JW. (2006) HIV tat and neurotoxicity. Microbes Infect. 8:1347-57.